Suppr超能文献

使用基于蛋白磷酸酶抑制的检测试剂盒评估蓝藻膳食补充剂中的微囊藻毒素污染情况。

Evaluation of microcystin contamination in blue-green algal dietary supplements using a protein phosphatase inhibition-based test kit.

作者信息

Marsan David W, Conrad Stephen M, Stutts Whitney L, Parker Christine H, Deeds Jonathan R

机构信息

University of Maryland Center for Environmental Studies, Institute of Marine and Environmental Technology, Baltimore, MD, USA.

United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.

出版信息

Heliyon. 2018 Mar 16;4(3):e00573. doi: 10.1016/j.heliyon.2018.e00573. eCollection 2018 Mar.

Abstract

The cyanobacterium (AFA), from Upper-Klamath Lake, Oregon, are used to produce blue-green algal (BGA) dietary supplements. The periodic co-occurrence of hepatotoxin-producing contaminant species prompted the Oregon Health Division to establish a limit of 1 μg/g microcystin (MC) for products sold in Oregon in 1997. At the federal level, the current good manufacturing practice (CGMP) regulations for dietary supplements require manufacturers establish a specification, and test, for limits on contaminants that may adulterate finished products. Despite this, several previous international surveys reported MC in BGA supplements in excess of 1 μg/g. The objectives of this study were (1) identify a reliable, easy to use test kit for the detection of MC in dried BGA materials and (2) use this kit to assess the occurrence of MC contamination in AFA-BGA dietary supplements in the U.S. A commercial protein phosphatase inhibition assay (PPIA), based on the enzyme PP2A, was found to have acceptable relative enzyme inhibition and accuracy for the majority of MC variants tested, including those most commonly identified in commercial samples, making the kit fit for purpose. Using the PPIA kit, 51% (26 of 51) distinct AFA-BGA products had MC ≥0.25 μg/g (the detection limit of the kit), 10 products had MC concentrations between 0.5 and 1.0 μg/g, and 4 products exceeded the limit (1.1-2.8 μg/g). LC-MS/MS confirmed PPIA results ≥0.5 μg/g and determined that MC-LA and MC-LR were the main congeners present. PPIA is a reliable method for the detection of MC contamination in dried BGA dietary supplements produced in the U.S. While the majority of AFA-BGA products contained ≥0.25 μg/g MC, most were at or below 1.0 μg/g, suggesting that manufacturers have adopted this level as a specification in these products; however, variability in recommended serving sizes prevented further analysis of consumer exposure based on the concentrations of MC contamination found.

摘要

来自俄勒冈州上克拉马斯湖的蓝藻(AFA)被用于生产蓝绿藻(BGA)膳食补充剂。产肝毒素污染物种类的周期性共存促使俄勒冈州卫生部门在1997年为在俄勒冈州销售的产品设定了1微克/克微囊藻毒素(MC)的限量。在联邦层面,现行的膳食补充剂良好生产规范(CGMP)法规要求制造商针对可能掺假成品的污染物限量制定规范并进行检测。尽管如此,此前的几项国际调查报道称BGA补充剂中的MC含量超过了1微克/克。本研究的目的是:(1)确定一种可靠、易于使用的检测试剂盒,用于检测干燥BGA材料中的MC;(2)使用该试剂盒评估美国AFA - BGA膳食补充剂中MC污染的发生情况。一种基于PP2A酶的商业蛋白磷酸酶抑制试验(PPIA),对于所测试的大多数MC变体,包括商业样品中最常见的变体,具有可接受的相对酶抑制率和准确性,使得该试剂盒符合要求。使用PPIA试剂盒,51%(51个中的26个)不同的AFA - BGA产品的MC≥0.25微克/克(该试剂盒的检测限),10种产品的MC浓度在0.5至1.0微克/克之间,4种产品超过了限量(1.1 - 2.8微克/克)。液相色谱 - 串联质谱法(LC - MS/MS)证实了PPIA结果≥0.5微克/克,并确定MC - LA和MC - LR是主要存在的同系物。PPIA是检测美国生产的干燥BGA膳食补充剂中MC污染的可靠方法。虽然大多数AFA - BGA产品含有≥0.25微克/克的MC,但大多数产品的含量处于或低于1.0微克/克,这表明制造商已将该水平作为这些产品的规范;然而,推荐服用量的差异使得无法根据所发现的MC污染浓度进一步分析消费者的暴露情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/791d/5968134/ddd7af319a83/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验